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Introduction 
During mitotic prophase of most eukaryotic cells, tran-
scription of the rRNA genes ceases and nucleolar struc-
ture breaks down. While some nucleolar protein compo-
nents remain associated with the chromosomal NORs, 
others bind to the surface of the chromosomes or become 
dispersed throughout the cytoplasm of dividing cells (see 
Tab. I in [1]). During telophase, nucleoli reform progres-
sively at the NORs in a process termed nucleologenesis 
(see [7, 21]). Experimentally, nucleologenesis can be di-
vided into two steps: i) assembly of prenucleolar bodies 
(PNBs) from dispersed nucleolar material derived from 
the mother cell and ii) subsequent fusion of PNBs around 
the NORs in a process which is dependent on the resump-
tion of rDNA transcription [3]. This conclusion was based 
on microinjection experiments in which antibodies to 
RNA polymerase I were introduced into mitotic cells in 
order to prevent reactivation of the rRNA genes. Daugh-
ter cells formed normally under such conditions with the 
notable exception that they lacked nucleoli since nucleo-
logenesis did not proceed beyond the PNB-stage [3,4]. 
Previous studies have shown that the enzyme DNA to-
poisomerase I is required for transcript elongation of pro-
tein-encoding as well as rRNA genes [6, 8, 10, 14, 16, 20, 
23]. Further studies indicated that DNA topoisomerase I 
activity can be selectively blocked by camptothecin, a drug 
Abbreviations. DMSO Dimethyl sulfoxide.-FITC Fluorescein 
isothiocyanate.-NOR Nucleolus organizer region.-PNB Pre-
nucleolar body.-PBS Phosphate buffered saline. 
I) Dr. Ricardo Benavente, Department of Cell and Developmen-
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with potential applications in tumor therapy (for review, 
see [13]). In the present study we have investigated the 
effects of camptothecin on postmitotic nucleolar reorgani-
zation. 
Materials and methods 
Camptothecin lactone (NSC-94600) was a gift of the Drug Synthe-
sis and Chemistry Branch of the ational Cancer Institute (Be-
thesda, MD/uSA). A stock solution of camptothecin was pre-
pared (10 mM in DMSO) and stored at -20°C. 
In order to investigate the effects of camptothecin on nucleolo-
genesis, protocols previously developed for similar studies with 
the D A-intercalating drug actinomycin D were followed [3]. 
PtK2 cells grown on coverslips were labeled at metaphase by mi-
croinjecting non-immune mouse IgGs. Camptothecin was then ad-
ded to the culture medium at a final concentration of 20 fLM for at 
least 2 h. Control experiments were performed by adding an equal 
volume of DMSO alone to the culture medium (final concentra-
tion 0.2%). 
Coverslips were fixed at various times after addition of the drug 
in methanol (-20°C) for 10 min, dipped for a few seconds in ace-
tone ( - 20°C) and air dried. The cells were then processed for 
double-label immunofluorescence microscopy. The distribution of 
the microinjected mouse IgGs was visualized by incubating the 
coverslips with anti-mouse IgG antibodies conjugated to Texas 
Red (Dianova, Hamburg/Germany) for 15 min. Then the speci-
mens were washed for 15 rnin in PBS and incubated with human 
autoantibodies against either the nucleolar protein fibrillarin [17] , 
D A topoisomerase I (kindly provided by Dr. H. Ponstingl, Ger-
man Cancer Reserarch Center, Heidelberg/Germany) or RNA 
polymerase I [19] for 15 min. Finally, the covers lips were washed 
in PBS and incubated with secondary anti-human IgG conjugated 
to FITC (Dianova; for further details, see [5]). 
Results and discussion 
In order to follow the time course of nucleologenesis, indi-
vidual PtK2 cells were labeled at metaphase by microinjec-
tion of non-immune mouse IgGs. After various times cells 
were then processed for immunofluorescence microscopy. 
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Mitosis proceeded normally under these experimental 
conditions. Daughter cells had entered interphase within 
2 h as judged by the decondensed state of their chromatin 
and the presence of distinct nucleoli (Fig. 1; see also [2]). 
Daughter cells derived from an injected mother cell could 
be clearly identified by the presence of mouse IgGs in the 
cytoplasm (Fig. 1 a). When probed with antibodies to the 
nucleolar protein fibrillarin, the newly formed nucleoli ex-
hibited a bright fluorescence which was indistinguishable 
from the nucleolar fluorescence of adjacent non-injected 
cells (Fig. 1 a '). Addition of 0.2% DMSO to the culture at 
the time of injection had no noticeable effects on postmi-
totic reformation of the nuclei and nucleoli of daughter 
cells (Fig. 1). 
In contrast, in the presence of camptothecin at concen-
trations known to inhibit D A topoisomerase I activity 
(see, e.g. [15]) nucleologenesis was severely inhibited. 
Metaphase cells exposed to the drug completed mitosis 
and divided normally. Two hours later, the nuclei of the 
resulting daughter cells appeared "empty" when viewed 
in phase contrast (Figs. 2a" , b" , c"). Ho~ever, antibodies 
to fibrillarin revealed a finely punctate ,Pattern of their nu-
clei resembling P Bs of early telophase (Fig. 2a '). Anti-
bodies to DNA topoisomerase I stained the nucleoplasm 
and a single prominent dot-like structure in each daughter 
nucleus which most probably corresponds to the OR 
(Fig. 2b'; the male PtK2 cells have only one NOR per 
chromosome set located on the X chromosome). The 
NOR was also positive for RNA polymerase I (Fig. 2c'). 
Earlier studies have shown that both types of enzyme 
molecules remain, at least in part, bound to the chromo-
somal NORs during normal mitosis [11, 22]. 
Treatment of interphase cells with camptothecin for 2 h 
caused a segregation of nucleolar components. This struc-
tural rearrangement and spatial separation of the nucleo-
lar components could be readily visualized by phase con-
trast optics in all non-injected cells (e.g., Fig. 2 a "). Ultra-
structural aspects of this process have already been de-
scribed (e.g., [9] and references therein). Antibodies to fi-
brillarin stained selectively the phase-light (i.e., dense fi-
brillar) component (Figs. 2a', a"; see also [18]) whereas 
RNA polymerase I and DNA topoisomerase I were pres-
ent in "caps" of the segregated nucleoli (Figs. 2 b' , b"; c' , 
c"; see also [20, 22]). Segregation of nucleolar compo-
nents can also be induced by other drugs such as actino-
mycin D which inhibit transcription (for review, see [12]). 
We therefore conclude that camptothecin-induced nucleo-
lar segregation is a consequence of blocked rDNA tran-
scription. 
The results of the present study demonstrate that camp-
tothecin not only causes nucleolar segregation but also in-
hibits postmitotic nucleolar reformation at the PNB stage. 
Since the activity of DNA topoisomerase I is required for 
transcription of the rRNA genes [6, 8, 10, 14, 16, 20, 23], 
the inability of PNBs to fuse around the NORs appears to 
be related to the inability of the rRNA genes to activate 
transcription. 
In a previous study we have shown that when postmito-
tic transcription of the rRNA genes was selectively 
blocked by microinjection of antibodies to RNA polymer-
ase I into metaphase cells, nucleologenesis was also ar-
rested at the PNB-stage [3]. This finding in conjunction 
with those presented above allow us to conclude that for-
mation of multiple PNBs in telophasic cells is independent 
- ~ Noo-immJne ~mouselgGs Doubre-Iabel immunofluorescence Phase contrast 
Fig. 1. Daughter cells reach interphase no later than 2 h after mi-
croinjection of non-immune IgGs into a dividing cell. To identify 
post mitotic cells, a metaphase PtK2 cell was Il}icroinjected with 
mouse IgGs and examined 2 h later by phase contrast (a") and 
double-label immunofluorescence microscopy. The distribution of 
the mouse IgGs is shown in a (only the daughter cell are labeled; 
note the exclusion of the IgGs from the nuclei). The nuclei of the 
daughter cells contain well developed nucleoli as seen by phase 
contrast (a") and immunofluorescence microscopy using anti-
bodies to fibrillarin (a'). Arrows denote the daughter cells.-Bar 
20f.Lm. 
European Journal of Cell Biology 61, 189-192 (1993) © Wi enschaftliche Verlagsgesellschaft mbH . Stullgart 
D. Weisenberger, U. Scbeer, R. Benavente: Postmitotic nucleolar reorganization 191 
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Fig. 2. Effect of camptothecin on nucleolar reformation. Dividing 
PtK2 cells were injected with non-immune mouse IgGs and cul-
tured for 2 h in the presence of camptothecin. Double-label im-
munofluorescence reveals the distribution of the mouse IgGs (~; 
arrows) as well as fibrillarin (a'), DNA topoisomerase I (b') and 
RNA polymerase I (c'). Arrowheads point to the putative ORs 
(b', c'). Note the absence of nucleoli in the post mitotic daughter 
cells as revealed by phase-contrast microscopy (a" -<" ). ucleoli of 
non-injected cells are segregated as a result of the camptothecin 
action (some are indicated by arrowheads in a', a").-Bar 20 Il-m. 
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of ongoing transcription (see also [7]). Studies using nuclei 
reconstituted from DNA in a cell-free Xenopus egg ex-
tract have further shown that assembly of PNBs occurs 
even in the absence of rDNA sequences [1]. In our view 
nascent transcripts of the rRNA genes establish a structur-
al link between an "active" NOR and the PNBs during 
normal nucleologenesis [3, 4, 21). Indeed we could locate 
fibrillarin, a protein present in PNBs as well as in the 
dense fibrillar component of interphase nucleoli , to the 
free 5' -ends of nascent pre-rRNA transcript fibrils by irn-
munogold electron microscopy of chromatin-spread prep-
arations [21]. The present study lends further support to 
the view that the nucleolus organizing activity of a NOR is 
directly related to the transcriptional activity of the rRNA 
genes. 
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